Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mei

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Oncogenesis|October 4, 2016
The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathwayH Mai, X Xu, G Mei, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Blood|June 14, 2022
Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphomaSwetha Kambhampati Thiruvengadam, Monica Saumoy, Yecheskel Schneider, et al.
Blood|August 1, 2022
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphomaSwetha Kambhampati Thiruvengadam, Monica Saumoy, Yecheskel Schneider, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Diabetes, Obesity & Metabolism|December 29, 2025
Association of clonal haematopoiesis and diabetes with outcomes after autologous haematopoietic cell transplantationRusha Bhandari, June-Wha Rhee, Sitong Chen, et al.
Journal of the National Cancer Institute|July 10, 2025
Clonal hematopoiesis and risk of non-myeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantationJune-Wha Rhee, Sitong Chen, Raju Pillai, et al.
JACC. Cardiooncology|February 3, 2025
Clonal Hematopoiesis and Risk of Heart Failure After Autologous Hematopoietic Cell Transplantation for LymphomaJune-Wha Rhee, Raju Pillai, Sitong Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2017
Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance RituximabMatthew G Mei, Thai M Cao, Lu Chen, et al.
Blood|March 22, 2022
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICEMatthew G Mei, Hun Ju Lee, Joycelynne M Palmer, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Oncogenesis|October 4, 2016
The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathwayH Mai, X Xu, G Mei, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Blood|June 14, 2022
Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphomaSwetha Kambhampati Thiruvengadam, Monica Saumoy, Yecheskel Schneider, et al.
Blood|August 1, 2022
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphomaSwetha Kambhampati Thiruvengadam, Monica Saumoy, Yecheskel Schneider, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Diabetes, Obesity & Metabolism|December 29, 2025
Association of clonal haematopoiesis and diabetes with outcomes after autologous haematopoietic cell transplantationRusha Bhandari, June-Wha Rhee, Sitong Chen, et al.
Journal of the National Cancer Institute|July 10, 2025
Clonal hematopoiesis and risk of non-myeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantationJune-Wha Rhee, Sitong Chen, Raju Pillai, et al.
JACC. Cardiooncology|February 3, 2025
Clonal Hematopoiesis and Risk of Heart Failure After Autologous Hematopoietic Cell Transplantation for LymphomaJune-Wha Rhee, Raju Pillai, Sitong Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2017
Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance RituximabMatthew G Mei, Thai M Cao, Lu Chen, et al.
Blood|March 22, 2022
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICEMatthew G Mei, Hun Ju Lee, Joycelynne M Palmer, et al.
Pageof 8